Published in Stem Cell Week, January 25th, 2010
"We here show that this FLT3-dependent stem cell maintenance system also plays a critical role in survival of leukemic stem cells (LSCs) in acute myeloid leukemia (AML). The CD34(+)CD38-LSC fraction expresses high levels of FLT3 as well as MCL-1, even compared with normal HSCs. Treatment with FLT3 ligand induced further MCL-1 up-regulation in LSCs in all AML cases tested. Interestingly, the group of samples...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week